Evid Based Nurs 7:50 doi:10.1136/ebn.7.2.50
  • Treatment

Review: regular inhaled short acting β2 agonists improve lung function in stable chronic obstructive pulmonary disease

 Q Is regular treatment with inhaled short acting β2 agonists (ISABAs) effective for stable chronic obstructive pulmonary disease (COPD)?


GraphicData sources:

Cochrane Collaboration trials register up to and including May 2002 and reference lists of review articles and retrieved studies.

GraphicStudy selection and assessment:

randomised, placebo controlled trials of ISABAs given to patients with stable COPD for ⩾7 days. Individual study quality was assessed on the basis of allocation concealment.


forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), peak expiratory flow rate (PEFR), breathlessness (visual analogue scale), treatment failure, and patient preference.


13 crossover trials met the …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article